Welcome to My Blog
Here is a masonry blog layout with no sidebarInsurers pay Rs18,600 crore for settling 15.40 lakh Covid-19 claims :IRDAI
“Over 19.11 lakh covid health claims have been reported as on 22nd June as far as medical insurance or hospitalisation is concerned. While in terms of death claims, which is handled by the life insurers, about 55,276 claims have been intimated and nearly 88 per cent i.e., 48,484 claims amounting to Rs 3,593 crore have already been settled,” informed while inaugurating 13th Global Insurance E-Summit & Awards organised by ASSOCHAM.
She added that the repudiated claim for health is just about 4 per cent and in life it is just about 0.66 per cent, which is negligible.
Thackeray instructs health dept to prepare for possible COVID third wave
Pfizer says Covid vaccine highly effective against Delta variant
“The data we have today, accumulating from research we are conducting at the lab and including data from those places where the Indian variant, Delta, has replaced the British variant as the common variant, point to our vaccine being very effective, around 90%, in preventing the coronavirus disease, COVID-19,” Alon Rappaport, Pfizer’s medical director in Israel, told local broadcaster Army Radio.
Delta variant ‘greatest threat’ to US’ COVID-19 efforts: Dr Fauci
”Similar to the situation in the UK, the Delta variant is currently the greatest threat in the US to our attempt to eliminate COVID-19,” Fauci told reporters during a virtual news conference here.
However, the “good news” is that the US vaccines are effective against the Delta variant, said Fauci, the head of the National Institutes of Allergy and Infectious Diseases (NIAID).
Private hospitals to log 15-17% revenue growth in FY22: Crisil
“While the second wave lashed again in April, the first quarter this fiscal will be sharply better on-year, with occupancy of 75 per cent, almost double on-year. This will be largely on account of a surge in Covid-19 treatments more than offsetting the deferral of elective surgeries and outpatient footfalls,” Crisil Ratings Senior Director Manish Gupta said.
As the second wave recedes in the second quarter, Crisil expects pent-up demand for non-Covid treatments to rebound and support occupancy, he added.
Some blood pressure-lowering medicines linked to less memory decline in older adults: Study
IRDAI allows home treatment as add-on cover in health insurance
Reacting to the development, Liberty General Insurance Ltd’s CEO and Whole Time Director Roopam Asthana told IANS that the “add-on cover has to be priced right taking into account the data and possible scenarios”.
Though the insurers will save on huge daily hospital room charges, the doctor and nurse fee may be on slightly on the higher side then what a hospital charges.
World Bank, African Union join forces to expand access to Covid-19 vaccines
Strive Masiyiwa, African Union special envoy, said the collaboration between the World Bank and African institutions such as the Africa Import Export Bank and the Africa Centre for Disease Control would provide the capacity to vaccinate at least 400 million people or 30% of the total African population.
India’s antitrust watchdog orders probe into Google in smart TVs suit
HDFC Life announces a bonus of Rs 2180 cr for its 15.49 lakh participating plans in FY 2021
15.49 lakh policyholders of HDFC Life Insurance are eligible for this bonus. ICICI Prudential Life Insurance declared its highest-ever annual bonus of Rs 867 crore for the policyholders for FY21.
Bajaj Allianz Life, has declared bonuses amounting to Rs. 1,156 crore to its policyholders. This includes a special one-time bonus of Rs. 315 crores, which is over and above the regular bonus.
Mongolia,Bahrain and Seychelles battling a surge in Covid-19 infections despite administering Chinese vaccine
All three put their faith, at least in part, in easily accessible Chinese-made vaccines, which would allow them to roll out ambitious inoculation programmes at a time when much of the world was going without.
But instead of freedom from the coronavirus, all three countries are now battling a surge in infections.China kicked off its vaccine diplomacy campaign last year by pledging to provide a shot that would be safe and effective at preventing severe cases of Covid-19.
SC reserves verdict on Rs 4 lakh ex-gratia compensation to kin of COVID-19 deceased
The top court asked the parties to file written submissions in three days and specifically directed the Centre to simplify the process of grant of death certificates to the dependents of those who have died of COVID-19.
The Centre had earlier told the apex court that the ex-gratia compensation of Rs 4 lakh cannot be paid to the families of those who have died of COVID-19 as the finances of state governments and the Centre are under severe strain.
‘If there is any fatality, we will hold state govt responsible’, SC tells AP
Swiss Re sells 6.6% in Phoenix for $610 mlnmillion
India reports around 40 cases of Delta plus variant
“As of now among the samples sequenced (45000+) in India, Delta plus variant — AY.1 –has been observed sporadically in Maharashtra, Kerala and Madhya Pradesh, with around 40 cases identified so far and no significant increase in prevalence,” the ministry said in its statement.
These three states have been advised to strengthen surveillance and take appropriate public health measures.
AstraZeneca Plc’s COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study.
The study by the Oxford University investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralize the Delta and Kappa variants, the statement said.
HC refuses to stay CCI notice to Facebook, WhatsApp in privacy policy matter
From burgers to airfare, discount offers stack up for inoculated Indians
KM Birla won’t buy firms with global supply chains, cites protectionism
China’s rapid economic rise in the past few years and the coronavirus pandemic more recently have exposed the vulnerabilities of global supply chains. This, in turn, has spurred almost every nation, be it the U.S., European Union or Australia, to turn inward, protect domestic enterprises and pursue self-reliance — a macroeconomic policy shift that has complicated growth plans for multinational corporations.